Out of the 2.7 million people bitten by venomous snakes each year, snakebite claims over 100,000 lives and maims another 400,000 victims for life.
Despite this, snakebite receives a disproportionately low level of attention. This has led to regions having insufficient levels of antivenom stocked, or lacking antivenom entirely. Snakebite also disproportionately affects the poorest and most marginalised members of society, and has a massive socio-economic burden.
In some cases, unscrupulous marketing has resulted in antivenoms from other regions being stocked instead, with lethal effects.
Associate Professor Bryan Fry discusses his research investigating not only critical deficiencies in treatment, but alternative treatments that may be suitable for remote communities.
Негізгі бет Ғылым және технология BrisScience (December 2019): Snakebite - the world's most neglected tropical disease
Пікірлер: 14